Health Effects of Biodiesel Exhaust Exposure
BD100
Cardiovascular Effects of Exposure to 100% Biodiesel Exhaust in Man
1 other identifier
interventional
19
1 country
1
Brief Summary
Urban air pollution is a major contributor to greenhouse gases and has been shown to increase cardiovascular mortality and morbidity. This century has seen a rebirth of biofuel marketing and research, with biodiesel emerging as one of the strongest contenders within international markets. The pursuit of alternative renewable fuels is incredibly complex and has powered research in agriculture, biotechnology, production, transportation, feedstocks, ecology and biomass manufacturing. In spite of this, health effects have been an almost completely overlooked aspect. The purpose of this study is to investigate whether 100% biodiesel exhaust exposure in healthy volunteers leads to cardiovascular and inflammatory responses. Further investigations into the chemical composition of biodiesel exhaust will also be performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 30, 2013
CompletedFirst Posted
Study publicly available on registry
June 21, 2013
CompletedJune 21, 2013
June 1, 2013
4 months
April 30, 2013
June 18, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vascular vasomotor and fibrinolytic function
Forearm venous occlusion plethysmography to measure forearm blood flow during unilateral intrabrachial infusion of endothelial-dependent and -independent vasodilators (bradykinin \& acetylcholine and sodium nitroprusside \& verapamil respectively). Tissue plasminogen activator and plasminogen activator inhibitor-1 were analysed in blood samples taken after bradykinin infusions in order to assess fibrinolytic function. These composite outcome measures will together indicate vascular vasomotor function.
4-6 hours after exposure
Secondary Outcomes (2)
Respiratory function tests
Baseline, 6 and 24 hours after exposure
Effects of exposure on metabolomic markers in plasma
Baseline and 2, 4 & 24 hours after exposure
Study Arms (2)
Diesel exhaust exposure
EXPERIMENTAL1 hour exposure to dilute diesel exhaust (approximate particle matter concentration 300 mcg/m3) during intermittent exercise
Biodiesel exhaust exposure
EXPERIMENTAL1 hour exposure to dilute biodiesel exhaust (generated at same running conditions as diesel exhaust) during intermittent exercise
Interventions
Measurement of forearm blood flow during unilateral intrabrachial infusion of four vasodilator drugs in incremental doses separated with 20-min washout periods. Bradykinin (endothelial-dependent vasodilator that releases t-PA) was infused at 100, 300 and 1000 pmol/min; acetylcholine (endothelial independent vasodilator that does not release t-PA) was infused at 5, 10 and 20 mcg/min; sodium nitroprusside (endothelial independent vasodilator that does not release t-PA) was infused at 2, 4 and 8 mcg/min and verapamil (endothelial independent and NO independent vasodilator that does not release t-PA) was infused at 10, 30 and 100 mcg/min. Bradykinin, acetylcholine and sodium nitroprusside were given in random order and verapamil was administered last due to its long acting effects.
Eligibility Criteria
You may qualify if:
- Non-smoking, healthy male subjects. All subjects undergo a general health examination and are required to have normal clinical examination, ECG, blood tests and lung function.
You may not qualify if:
- Diabetes Mellitus
- Cardiovascular disease
- Asthma
- Respiratory infection within 2 weeks of the study
- Antioxidant- and/or vitamin supplementation within 1 week prior to, as well as during the course of the study. (incl vitamin C, Acetylcysteine)
- Smokers or regular snus usage
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Umeå Universitylead
- University of Edinburghcollaborator
Study Sites (1)
Umeå University Hospital
Umeå, 90185, Sweden
Related Publications (1)
Unosson J, Kabele M, Boman C, Nystrom R, Sadiktsis I, Westerholm R, Mudway IS, Purdie E, Raftis J, Miller MR, Mills NL, Newby DE, Blomberg A, Sandstrom T, Bosson JA. Acute cardiovascular effects of controlled exposure to dilute Petrodiesel and biodiesel exhaust in healthy volunteers: a crossover study. Part Fibre Toxicol. 2021 Jun 14;18(1):22. doi: 10.1186/s12989-021-00412-3.
PMID: 34127003DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Jenny A Bosson, MD, PhD
Umeå University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 30, 2013
First Posted
June 21, 2013
Study Start
September 1, 2012
Primary Completion
January 1, 2013
Study Completion
April 1, 2013
Last Updated
June 21, 2013
Record last verified: 2013-06